Sven Schnichels graduated from the University of Hohenheim in 2005. In 2006 he joined the Eberhard Karls University in Tübingen (EKUT) for his PhD, which he conducted at the University Eye Hospital. He continued his Post-Doc at the University Eye Hospital in Tübingen and became the Laboratory Head of the Eye Hospital in 2013.
Since 2016, he is also the head of the Neuroprotection and Drug Delivery Lab at the Institute for Ophthalmic Research at EKUT. In addition, he is a member of the board of the German Ophthalmological Society (DOG). Furthermore, he is one of the spokespersons of the YoungDOG, representing the young members of the DOG. He is also an appointed member of the European Leadership Development Program of the European Society of Ophthalmology.
His research interests include innovative drug-delivery systems and testing of neuroprotective agents for retinal diseases. In addition, to create more realistic models for human ocular diseases and to implement the 3R principles, he started in 2010 to develop several ex vivo and in vitro cornea, retina and spheroid models.
He authored more than 70 publications and two patents, supervised 5 Post-Docs, 7 clinician-scientists, 9 PhDs, 6 master’s students, and 20 medical thesis students.